Unknown

Dataset Information

0

Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia.


ABSTRACT: Abnormalities of molecules involved in signal transduction pathways are connected to Chronic Lymphocytic Leukemia (CLL) pathogenesis and a critical role has been already ascribed to B-Cell Receptor (BCR)-Lyn axis. E3 ubiquitin ligase c-Cbl, working together with adapter protein CIN85, controls the degradation of protein kinases involved in BCR signaling. To investigate cell homeostasis in CLL, we studied c-Cbl since in normal B cells it is involved in the ubiquitin-dependent Lyn degradation and in the down-regulation of BCR signaling. We found that c-Cbl is overexpressed and not ubiquitinated after BCR engagement. We observed that c-Cbl did not associate to CIN85 in CLL with respect to normal B cells at steady state, nor following BCR engagement. c-Cbl association to Lyn was not detectable in CLL after BCR stimulation, as it happens in normal B cells. In some CLL patients, c-Cbl is constitutively phosphorylated at Y731 and in the same subjects, it associated to regulatory subunit p85 of PI3K. Moreover, c-Cbl is constitutive associated to Cortactin in those CLL patients presenting Cortactin overexpression and bad prognosis. These results support the hypothesis that c-Cbl, rather than E3 ligase activity, could have an adaptor function in turn influencing cell homeostasis in CLL.

SUBMITTER: Martini V 

PROVIDER: S-EPMC6114956 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9735720 | biostudies-literature
| S-EPMC5173040 | biostudies-literature
| S-EPMC6155045 | biostudies-literature
| S-EPMC5727250 | biostudies-literature
| S-EPMC5336551 | biostudies-literature
| S-EPMC6995694 | biostudies-literature
| S-EPMC5093209 | biostudies-literature
2018-09-19 | PXD010401 | Pride
| S-EPMC9606825 | biostudies-literature
| S-EPMC4796351 | biostudies-literature